Unknown

Dataset Information

0

Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab.


ABSTRACT: A patient with COVID-19-related severe respiratory failure, with insufficient response to an antiretroviral therapy, hydroxychloroquine and Interleukin-6 (IL-6) antagonist therapy, presented a prompt resolution of the respiratory function and improvement in the radiological picture after baricitinib at an oral dose of 4 mg per day for 2 weeks.

SUBMITTER: Cingolani A 

PROVIDER: S-EPMC7340855 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7410892 | BioStudies
2020-01-01 | S-EPMC7527941 | BioStudies
2017-01-01 | S-EPMC5347954 | BioStudies
2020-01-01 | S-EPMC7227095 | BioStudies
2020-01-01 | S-EPMC7046961 | BioStudies
2017-01-01 | S-EPMC5604362 | BioStudies
1000-01-01 | S-EPMC6251844 | BioStudies
2019-01-01 | S-EPMC6618316 | BioStudies
2017-01-01 | S-EPMC6402191 | BioStudies
2019-01-01 | S-EPMC6560251 | BioStudies